When SLE CD8+ T cells were treated with a known oxidant (menadione) or antioxidant (NAC), we found that SLE CD8+ T cells responded better to NAC with a significant reduction in IFN-γ production (Figure 4A,G). Here, CD8A is linked to systemic lupus erythematosus.